Log in
Enquire now
‌

US Patent 9763743 Apparatus and method for treating rhinitis

Patent 9763743 was granted and assigned to Arrinex, Inc. on September, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Arrinex, Inc.
0
Date Filed
July 24, 2015
0
Date of Patent
September 19, 2017
0
Patent Applicant
‌
Arrinex, Inc.
0
Patent Application Number
14808690
0
Patent Citations Received
‌
US Patent 11666378 Systems and methods for therapeutic nasal neuromodulation
0
‌
US Patent 11684414 Systems and methods for therapeutic nasal neuromodulation
0
‌
US Patent 11701167 Systems and methods for therapeutic nasal neuromodulation
0
‌
US Patent 11744454 Speculum
‌
US Patent 11744568 Illuminated medical devices
‌
US Patent 11759222 Methods and devices to treat nasal airways
‌
US Patent 11766286 Methods and devices to treat nasal airways
‌
US Patent 12089829 Illuminated surgical retractor
0
‌
US Patent 11771497 Devices for therapeutic nasal neuromodulation and associated methods and systems
‌
US Patent 11801084 Methods and devices to treat nasal airways
•••
Patent Inventor Names
David Moosavi
0
Bryant Lin
0
Mojgan Saadat
0
Vahid Saadat
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9763743
0
Patent Primary Examiner
‌
Michael Peffley
0

Find more entities like US Patent 9763743 Apparatus and method for treating rhinitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.